To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
21 U.S.C. 321, 355, 356c, 360
and
379j-41 41 U.S.C. 6303 42 U.S.C. 262
and
262
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Rolling Active Pharmaceutical Ingredient and Drug Reserve Act. H.R. 3955. 119th
Cong., 1st
sess., Introduced in House June 12, 2025. https://www.govinfo.gov/app/details/BILLS-119hr3955ih.
APA
Congress, House of Representatives (2025, June 12). Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 3955 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr3955ih.
MLA
United States, Congress, House of Representatives. Rolling Active Pharmaceutical Ingredient and Drug Reserve Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr3955ih. 119th Congress, H.R. 3955, Introduced in House 12 Jun. 2025.
Bluebook
H.R.3955 - 119th Congress (2025-2026): Rolling Active Pharmaceutical Ingredient and Drug Reserve Act, H.R.3955, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr3955ih.
